Nabla, founded in 2018, builds ambient AI assistants for clinical documentation. The company's core product listens to patient-clinician conversations and generates structured clinical notes in seconds, combining ambient listening, dictation, and clinical nudges. It integrates with all major electronic health record (EHR) systems and supports more than 35 languages. Nabla's assistant is deployed across 150+ healthcare organisations and used by more than 85,000 clinicians.
The company was founded by Alexandre Lebrun, Delphine Groll, and Martin Raison, who previously built AI systems at Facebook and Wit.ai. Nabla's technical stack spans speech-to-text, natural language processing, and EHR integration. Yann LeCun, former Chief AI Scientist at Meta, serves as an advisor. Dr. Ed Lee, former CIO of The Permanente Federation, is Chief Medical Officer. The company has raised $120M from investors including HV Capital, Highland Europe, and Cathay Innovation.
Nabla is developing an Adaptive Agentic Platform, a next-generation system intended to extend beyond documentation into clinical coding assistance and proactive EHR actions across diverse care settings. The platform is designed to operate as a more autonomous assistant within clinical workflows.
The company's stated mission centres on reducing the documentation burden that its founders describe as consuming up to two hours of a clinician's day, with the goal of restoring time for direct patient care and addressing clinician burnout.